Oyster Point Pharma, Inc. Net Income
Oyster Point Pharma, Inc. reported Net Income of -$36.75 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2022-11-10
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$36.75M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2022-06-30 was -$49.94M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2022-03-31 was -$47.89M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for the quarter ending 2021-12-31 was -$42.06M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for fiscal 2021 was -$100.66M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for fiscal 2020 was -$70.52M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for fiscal 2019 was -$45.71M.
- Oyster Point Pharma, Inc. net income (loss) attributable to parent for fiscal 2018 was -$16.50M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | -$36.75M 10-Q · filed 2022-11-10 | -$86.69M derived: sum of 2 quarters · filed 2022-11-10 | -$134.58M 10-Q · filed 2022-11-10 | -$176.65M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | -$49.94M 10-Q · filed 2022-11-10 | -$97.83M 10-Q · filed 2022-08-11 | -$139.90M derived: sum of 3 quarters · filed 2022-11-10 | -$157.57M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | -$47.89M 10-Q · filed 2022-11-10 | -$89.96M derived: sum of 2 quarters · filed 2022-11-10 | -$107.63M derived: sum of 3 quarters · filed 2022-11-10 | -$129.64M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-12-31 | -$42.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$59.73M derived: sum of 2 quarters · filed 2022-11-10 | -$81.75M derived: sum of 3 quarters · filed 2022-11-10 | -$100.66M 10-K · filed 2022-02-24 | |
| 2021-09-30 | -$17.67M 10-Q · filed 2022-11-10 | -$39.69M derived: sum of 2 quarters · filed 2022-11-10 | -$58.59M 10-Q · filed 2022-11-10 | -$80.83M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$22.02M 10-Q · filed 2022-11-10 | -$40.92M 10-Q · filed 2022-08-11 | -$63.16M derived: sum of 3 quarters · filed 2022-11-10 | -$79.46M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-03-31 | -$18.91M 10-Q · filed 2022-11-10 | -$41.14M derived: sum of 2 quarters · filed 2022-11-10 | -$57.45M derived: sum of 3 quarters · filed 2022-11-10 | -$72.91M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2020-12-31 | -$22.23M 10-K · filed 2021-02-18 | -$38.54M derived: sum of 2 quarters · filed 2021-11-04 | -$54.00M derived: sum of 3 quarters · filed 2021-11-04 | -$70.52M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$16.30M 10-Q · filed 2021-11-04 | -$31.77M derived: sum of 2 quarters · filed 2021-11-04 | -$48.29M 10-Q · filed 2021-11-04 | -$68.01M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$15.46M 10-Q · filed 2021-11-04 | -$31.98M 10-Q · filed 2021-08-05 | -$51.71M derived: sum of 3 quarters · filed 2021-11-04 | -$63.20M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-03-31 | -$16.52M 10-Q · filed 2021-11-04 | -$36.24M derived: sum of 2 quarters · filed 2021-11-04 | -$47.74M derived: sum of 3 quarters · filed 2021-11-04 | -$58.47M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2019-12-31 | -$19.72M 10-K · filed 2021-02-18 | -$31.22M derived: sum of 2 quarters · filed 2021-02-18 | -$41.95M derived: sum of 3 quarters · filed 2021-02-18 | -$45.71M 10-K · filed 2021-02-18 | |
| 2019-09-30 | -$11.50M 10-K · filed 2021-02-18 | -$22.23M derived: sum of 2 quarters · filed 2021-02-18 | -$25.99M 10-Q · filed 2020-11-05 | -$30.00M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-06-30 | -$10.73M 10-K · filed 2021-02-18 | -$10.73M 10-Q · filed 2019-12-03 | -$14.49M 10-Q · filed 2020-08-05 | -$18.50M derived: sum of 3 quarters · filed 2021-02-18 | -$25.13M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | -$3.76M 10-K · filed 2021-02-18 | -$3.76M 10-Q · filed 2019-12-03 | -$7.77M derived: sum of 2 quarters · filed 2021-02-18 | -$14.40M derived: sum of 3 quarters · filed 2021-02-18 | -$17.33M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | -$4.01M 10-K · filed 2020-02-27 | -$10.64M derived: sum of 2 quarters · filed 2020-02-27 | -$13.57M derived: sum of 3 quarters · filed 2020-02-27 | -$16.50M 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$6.63M 10-K · filed 2020-02-27 | -$9.56M derived: sum of 2 quarters · filed 2020-02-27 | -$12.49M 10-Q · filed 2019-12-03 | ||
| 2018-06-30 | -$2.93M 10-K · filed 2020-02-27 | -$2.92M 10-Q · filed 2019-12-03 | -$5.86M derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2018-03-31 | -$2.93M 10-K · filed 2020-02-27 | -$2.94M 10-Q · filed 2019-12-03 |